free experimental infectious hoped supply donald cocktail earlier pain giving critical wrote drug halts cnn customary saying clear victoria desantis normal age efficacy drugs study washington ultrarare risk therapy yancopoulos

Articles for Regeneron

Regeneron ISEF 2024: How I fell in and out of love with science fairs.
7 months, 1 week ago

Regeneron ISEF 2024: How I fell in and out of love with science fairs.

Slate  

The year was 2023, and I was at my version of the Super Bowl: the Regeneron International Science and Engineering Fair. judge frowned and asked me, “How will doctors continue to make a living if patients go home quickly?” Another asked, “Isn’t this whole thing a bit dark for a science fair project?” I had a choice: either be honest …

School Competition Projects Project Fairs Science Fairs Science Fair
DeSantis blasts FDA for halting drugs ineffective on omicron
2 years, 10 months ago

DeSantis blasts FDA for halting drugs ineffective on omicron

Associated Press  

TALLAHASSEE, Fla. — Florida Gov. Ron DeSantis pushed Tuesday for coronavirus patients to continue receiving antibody treatments deemed ineffective against the omicron variant, vowing to fight White House health regulators in his latest feud with President Joe Biden. At a news conference Tuesday, DeSantis referenced anecdotal cases in which people were helped by the monoclonal antibody treatments and said it …

Drugs White House Republican Biden Drug Desantis Fda
FDA halts use of antibody drugs that don’t work vs. omicron
2 years, 11 months ago

FDA halts use of antibody drugs that don’t work vs. omicron

Associated Press  

WASHINGTON — COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don’t work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday. But officials resumed distribution after complaints from Republican governors, including Florida’s Ron DeSantis, who claimed that the drugs continued to help some omicron patients. …

Drugs Drug Fda Lilly Omicron Antibody Remdesivir
DeSantis demands Feds allow Florida to buy $1 Billion in COVID treatment top donor has invested in
2 years, 11 months ago

DeSantis demands Feds allow Florida to buy $1 Billion in COVID treatment top donor has invested in

Raw Story  

Ron DeSantis has returned to public view after a two-week absence where he was accused of being "MIA" during record-breaking coronavirus case counts. On Monday the Republican governor held a press conference to blast President Joe Biden, demanding he allow Florida purchase a COVID-19 treatment that is manufactured by a company one of his top donors has heavily invested in. …

Treatment Covid Desantis Ron Desantis Ron Monoclonal Antibody Regeneron
Evusheld to prevent Covid-19: There won’t be nearly enough for Americans who are eligible
3 years ago

Evusheld to prevent Covid-19: There won’t be nearly enough for Americans who are eligible

CNN  

CNN — For Americans who suffer from weak immune systems, it felt like a miracle occurred on December 8. When asked why the government thus far has contracted for only the 700,000 doses, Cicely Waters, an HHS spokesperson, said that “primary protection from COVID-19 related disease including immunocompromised populations is still through vaccination.” But it’s likely that millions of immune-compromised …

Florida Patients Vaccines Cnn Covid Cdc Fda
What you should know about treating Covid-19
3 years ago

What you should know about treating Covid-19

Live Mint  

Within a few weeks, the US could have access to the first antiviral pills to treat Covid-19, either from Pfizer Inc. or Merck & Co. and partner Ridgeback Biotherapeutics LP. Doctors say an initial step is to monitor symptoms to determine whether infected people could be considered at low or high risk for developing severe disease. Patients who don’t respond …

Disease Treatment Patients Risk Covid Drug Icu
WHO recommends antibody treatment for COVID-19 infected people who have a high risk of hospitalisation
3 years, 3 months ago

WHO recommends antibody treatment for COVID-19 infected people who have a high risk of hospitalisation

Firstpost  

The Regeneron cocktail of synthetic antibodies - casirivimab and imdevimab - has been found to reduce the risk of hospitalisation for unvaccinated, elderly or immunosuppressed patients with Covid. The World Health Organization on Friday recommended the synthetic antibody treatment Regeneron for Covid-19, but only in patients with specific health profiles. Regeneron is only the third treatment for Covid to be …

Health Treatment Patients Covid Antibody Regeneron
Coronavirus updates | September 24, 2021
3 years, 3 months ago

Coronavirus updates | September 24, 2021

The Hindu  

The World Health Organization on September 24 recommended the synthetic antibody treatment Regeneron for Covid-19, but only in patients with specific health profiles. - Reuters WHO recommends antibody treatment for critical Covid patients COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organization …

Health India Singapore China Tamil Nadu Delhi Vaccination
Anti-vaccine, anti-mask governors push an experimental antibody therapy
3 years, 4 months ago

Anti-vaccine, anti-mask governors push an experimental antibody therapy

LA Times  

With COVID-19 hospitalizations soaring in Florida, Gov. Antibody cocktails, which must be given within 10 days of coronavirus infection or exposure, are effective for many patients, but “this is not a substitute for vaccine, by any means,” said Dr. Christian Ramers, chief of population health and an infectious-disease specialist at Family Health Centers of San Diego. The Food and Drug …

Health Florida Therapy Patients Vaccines Desantis Delta
Regeneron: Covid-19 antibody treatments work, but they’re ‘not the path out of this pandemic’
3 years, 4 months ago

Regeneron: Covid-19 antibody treatments work, but they’re ‘not the path out of this pandemic’

CNN  

CNN — When Texas Gov. Monoclonal antibodies such as those made by Regeneron and GlaxoSmithKline won’t work for every Covid-19 patient; mAbs, as they are known, are only available for people age 12 and older and who aren’t hospitalized or severely ill. Regeneron’s therapy can also be used for some people who know they were exposed to the virus,but don’t …

Treatment Protection Work Patients Cnn Covid Fda
As Covid-19 cases spike US orders for monoclonal antibodies up 1200%
3 years, 4 months ago

As Covid-19 cases spike US orders for monoclonal antibodies up 1200%

CNN  

CNN — As coronavirus case numbers spike, the US has seen a 1,200% increase in orders for monoclonal antibody treatments in the past month, the US Health and Human Services Department told CNN Thursday. “This, applied early and properly, has the ability to reduce your likelihood of being hospitalized.” Studies show monoclonals are highly effective at preventing high-risk patients from …

Florida Cnn Covid Treatments Hhs Lilly Antibody
The Latest: India's Taj Mahal reopens as new infections slow
3 years, 6 months ago

The Latest: India's Taj Mahal reopens as new infections slow

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy NEW DELHI — India is …

India Europe Florida Pandemic Disney California New Mexico
Antibody cocktail to treat Covid-19 now in India. What is it? Who should take the therapy?
3 years, 6 months ago

Antibody cocktail to treat Covid-19 now in India. What is it? Who should take the therapy?

India Today  

An 84-year-old man from Haryana, who was the first Covid-19 patient in India to receive an antibody drug cocktail authorised by the Centre earlier this month, has been discharged from hospital. The antibody cocktail shot into the limelight after it was used to treat former United States President Donald Trump last year. The antibody cocktail is to be administered for …

India Therapy Patients Treat Cocktail Roche Antibody
Swiss Pharma Giant Roche Reports Promising Results from Anti-Covid Cocktail
3 years, 9 months ago

Swiss Pharma Giant Roche Reports Promising Results from Anti-Covid Cocktail

News 18  

Swiss pharma giant Roche announced Tuesday promising results from clinical trials of an anti-Covid cocktail developed with US biotech firm Regeneron. Levi Garraway, Roche’s chief medical officer and head of global product development, said “new infections continue to rise globally with over three million reported cases last week. “This investigational antibody cocktail may offer hope as a potential new therapy …

Treatment Cocktail Roche Regeneron Reports Promising
Regeneron to stop giving placebo in Covid-19 drug trial after 'clear efficacy'
3 years, 9 months ago

Regeneron to stop giving placebo in Covid-19 drug trial after 'clear efficacy'

Hindustan Times  

Regeneron Pharmaceuticals said on Thursday that an independent panel found the company's Covid-19 antibody cocktail to have "clear clinical efficacy" in reducing the rates of hospitalization and deaths in patients. In January, the US government said it will buy 1.25 million additional doses of Regeneron Pharmaceuticals' Covid-19 antibody cocktail. Independent Data Monitoring Committee found that both 1,200mg and 2,400mg doses …

Million Doses Regeneron Regeneron Pharmaceuticals
US pharmaceutical Eli Lilly's, biotech firm Regeneron's Covid-19 antibodies study data shows promising results
3 years, 10 months ago

US pharmaceutical Eli Lilly's, biotech firm Regeneron's Covid-19 antibodies study data shows promising results

Hindustan Times  

US pharmaceutical company Eli Lilly's combination of two synthetic antibodies against Covid-19 reduced hospitalizations and deaths by 70 percent in high-risk patients with recent positive tests, the company said Tuesday. "Bamlanivimab and etesevimab together have the potential to be an important treatment that significantly reduces hospitalizations and death in high-risk COVID-19 patients," Lilly's chief scientific officer Daniel Skovronsky said. - …

Patients Covid Drug Reduce High Risk Lilly Placebo
Monoclonal antibodies: A Covid-19 treatment people might not know about
4 years ago

Monoclonal antibodies: A Covid-19 treatment people might not know about

CNN  

CNN — There are very few drugs that prevent people with early Covid-19 from progress to severe disease, but monoclonal antibodies may be among them. “The monoclonal antibodies we’ve authorized seem to work best for preventing hospitalization in outpatients early in their disease – typically within 10 days of the onset of symptoms, if you are a high-risk individual. The …

Health Treatment Supply Patients Care Cnn Covid
Rudy Giuliani admits he had COVID-19 symptoms when he traveled to four states in five days
4 years ago

Rudy Giuliani admits he had COVID-19 symptoms when he traveled to four states in five days

Daily Mail  

Rudy Giuliani has revealed he was showing coronavirus symptoms for several days but continued to travel to four states in five days before he was hospitalized with the disease earlier this week. The former New York City Mayor claimed that despite continuing to travel while showing symptoms for the virus, he would not change how he has responded to the …

Court States Trump Election Texas Michigan New York
I got ultra-rare Regeneron to cure my COVID, Rudy Giuliani says
4 years ago

I got ultra-rare Regeneron to cure my COVID, Rudy Giuliani says

Daily Mail  

Rudy Giuliani has revealed that he was treated with a rare and in-demand experimental drug while he was hospitalized with the coronavirus – making him just the latest powerful Donald Trump associate to get special care. Giuliani, who has been heading Trump's legal effort to overturn the election results, told the New York Daily News he had in fact been …

Treatment White House Hospital New York Donald Trump Covid President Trump
US scientists develop nasal spray to prevent COVID-19, effective for six months
4 years ago

US scientists develop nasal spray to prevent COVID-19, effective for six months

Firstpost  

A key advantage of this approach is that it doesn’t need a competent immune system for it to be effective in preventing COVID-19. Scientists at the University of Pennsylvania and the biotech firm Regeneron are investigating whether technology developed for gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus. “The advantage …

Wilson Penn Cells Nasal Spray Regeneron
U.S. FDA grants emergency use authorization to...
4 years, 1 month ago

U.S. FDA grants emergency use authorization to...

Daily Mail  

The FDA on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc's COVID-19 antibody therapy, an experimental treatment given to President Donald Trump that he said helped cure him of the disease. The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive …

Treatment Patients Experimental Drug Fda Antibodies Antibody
Carson says he’s ‘out of the woods’ after battling COVID-19
4 years, 1 month ago

Carson says he’s ‘out of the woods’ after battling COVID-19

Associated Press  

STERLING, Va. — Housing Secretary Ben Carson is crediting unapproved, experimental treatments with saving his life after he became “desperately ill” following his infection with the coronavirus. A retired neurosurgeon, Carson said Friday that he believes he’s now “out of the woods.” He disclosed that his wife, Candy, also had COVID-19, the disease the coronavirus causes. Carson said he has …

Carson Regeneron Trump Experimental Treatment
FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment
4 years, 1 month ago

FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment

NPR  

FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment Enlarge this image toggle caption Susan Walsh/AP Susan Walsh/AP One of the experimental drugs that President Trump received while he was battling the coronavirus has been approved for emergency use by the Food and Drug Administration. The drug, made by the biotech company Regeneron, is the second antibody treatment to …

Treatment Emergency Drug Fda Eli Lilly Authorization Regeneron
Ben Carson says he beat COVID-19 after President Trump cleared him for monoclonal antibody therapy
4 years, 1 month ago

Ben Carson says he beat COVID-19 after President Trump cleared him for monoclonal antibody therapy

Daily Mail  

Housing Secretary Ben Carson is crediting President Trump with 'clearing him' for unapproved, experimental treatments that he says 'saved his life' after he became 'desperately ill' following his infection with the coronavirus. Housing and Urban Development Secretary Ben Carson posted a message on Facebook in which he describes being 'desperately ill' from COVID-19 The Facebook post included a photo of …

Medical Treatment Trump Therapy White House President Drug